Pediatrix Medical (MD) Income from Continuing Operations (2009 - 2026)

Pediatrix Medical (MD) has reported Income from Continuing Operations for 18 consecutive years, with $39.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Income from Continuing Operations rose 1.48% year-over-year to $39.8 million in Q2 2026; TTM through Jun 2026 was $174.8 million, a 59.03% increase from a year earlier, with the FY2025 full-year figure at $165.4 million, up 266.94% from the prior year.
• Income from Continuing Operations was $39.8 million for Q2 2026 at Pediatrix Medical, up from $29.6 million in the prior quarter.
• Over five years, Income from Continuing Operations peaked at $71.7 million in Q3 2025 and troughed at -$153.0 million in Q2 2024.
• A 5-year average of $7.6 million and a median of $25.9 million in 2022 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations slumped 641.07% in 2024 and jumped 413.93% in 2025, its largest moves.
• Over 5 years, Income from Continuing Operations stood at $23.6 million in 2022, then sank by 626.46% to -$124.3 million in 2023, then jumped by 124.52% to $30.5 million in 2024, then rose by 10.51% to $33.7 million in 2025, then advanced by 18.29% to $39.8 million in 2026.
• The last three Income from Continuing Operations figures came in at $39.8 million (Q2 2026), $29.6 million (Q1 2026), and $33.7 million (Q4 2025), per Business Quant data.